Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
DOCU has climbed 6% this week to $72.31, but the more interesting development is in what the market's own positioning reveals: short sellers are retreating at pace while options traders are hedging at the most defensive level of the past year, two signals pointing in different directions.
The short interest story is one of steady unwinding. DOCU's short interest has fallen 13% in a week and 20% over the past month, bringing it to 5.6% of the free float, down from above 7% in mid-September. The borrow market is extremely loose: availability runs at nearly 7,600%, meaning roughly 76 shares are available to lend for every one already borrowed, a pool that has only deepened as short sellers have returned stock. Borrowing costs have ticked up 41% in the week to 0.39%, but from such a low base that the absolute rate still signals no meaningful squeeze pressure. The ORTEX short score has also dropped to 41.2 from around 44 a week ago, consistent with shorts covering into the rally rather than building fresh positions.
Options tell a more cautious story. The put/call ratio has reached 1.28, the highest reading of the past 52 weeks and roughly 1.3 standard deviations above its 20-day average of 1.20. That elevated put demand looks less like outright bearish positioning and more like investors protecting gains on a stock that has now risen 10% over the past month. The tension is worth naming: short sellers are leaving, but options buyers are hedging. The two moves are not necessarily contradictory, but they do reflect a market that is not uniformly comfortable with the stock at these levels.
The Street remains stuck in neutral. After DocuSign's last earnings print in early September, a wide group of analysts raised price targets while keeping ratings unchanged. Morgan Stanley went to $75 from $69 at Equal-Weight. Citigroup moved to $72 from $54, also at Neutral. Bank of America raised its Underperform target to $64 from $58. The mean target across the consensus sits at roughly $70, a level the stock has now moved above at $72.31. With 14 analysts on Hold and the consensus at Hold, the stock has effectively caught up to where its most recent target revisions were pointing. The bull case rests on DocuSign's IAM platform reaching $529 million and 15.1% of total ARR, strong free cash flow generation, and raised full-year guidance. Bears point to persistent e-signature concentration risk, a history of guidance misses in 2023 and a workforce reduction that complicates the growth story. The forward earnings revision factor scores in the 81st percentile, suggesting analysts have meaningfully lifted profit expectations, but the EV/EBIT factor sits in only the 34th percentile, indicating the valuation is not compelling to value-oriented screens.
One data point from DocuSign's own filings stands out: the company repurchased 6.79 million shares in Q2, up 200% on the same quarter a year earlier, spending $317.5 million, a 73% increase year-on-year. That pace of capital return is a material signal about management's confidence in the balance sheet, even as the same management team was selling shares through pre-arranged 10b5-1 plans on October 1. CEO Allan Thygesen sold roughly 26,000 shares worth close to $1.8 million that day, alongside the Chief Revenue Officer and Chief Legal Officer. All trades were executed under 10b5-1 plans, meaning they were scheduled in advance rather than discretionary, which limits their signal value. Retail attention is also running slightly above its recent norm, with ORTEX's Wikipedia-based attention tracker logging a z-score of 1.6 as of late September.
The next earnings date is December 3. With the stock already above where most analysts moved their targets after the September print, and the put/call ratio at a year-high even as shorts exit, what to watch is whether options hedging fades as the stock consolidates, or whether the defensive bid in puts holds even as the short community continues to step back.
See the live data behind this article on ORTEX.
Open DOCU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
